Sixera Pharma

http://sixerapharma.com/

Last activity: -

Active

Categories: Skin

Sixera is developing a NCE, SXR1096 for the treatment of a ultra-orphan skin disease called Netherton syndrome. SXR1096 is a small molecule formulated in a cream to be applied topically on the skin.

Location: Sweden, Stockholm

Investors 1

Date	Name	Website
-	Flerie Inv...	flerie.com

Reviews 0

Sign up to leave a review

Sign up Log In